Embryonic Development in Assisted Reproductive Technologies

Assisted reproductive technologies (ART) encompass a suite of laboratory and clinical interventions designed to overcome infertility by supporting fertilisation and early embryo development outside the maternal body. Central to ART is the transition of the fertilised oocyte, or zygote, through sequential cleavage divisions, morula compaction and blastocyst formation. During this period, culture media, incubation conditions and non-invasive imaging techniques exert a profound influence on cellular synchrony, genomic stability and lineage specification. Advances in time-lapse monitoring have refined the precision of morphokinetic assessment, thereby enhancing embryo selection strategies. Concurrently, innovations in cryopreservation—particularly vitrification—have improved survival rates of both zygotes and blastocysts, enabling flexible transfer schedules and cumulative live birth outcomes. Preimplantation genetic testing and molecular ploidy analysis further inform the identification of euploid embryos, maximising implantation potential while minimising transfer of aneuploid or mosaic embryos. Collectively, these developments have yielded tangible improvements in clinical success rates, expanded the pool of viable embryos, and underscored the importance of tailored laboratory protocols. Ongoing research continues to refine our understanding of the cellular and molecular events that underpin embryo competence, with the ultimate aim of increasing the safety, efficacy and accessibility of ART worldwide.

Research from Nature Portfolio

Recent studies have demonstrated that supplementing blastocyst-warming solutions with specific fatty acids enhances in vitro outgrowth and clinical pregnancy outcomes. Laboratory assays comparing fatty acid-enriched and control warming media revealed significantly larger trophoblast expansion and reduced degeneration in treated blastocysts. A matched retrospective analysis of single vitrified-warmed blastocyst transfers confirmed higher rates of implantation, clinical pregnancy and ongoing pregnancy for the fatty acid group. In parallel, time-lapse monitoring investigations have improved the detection and classification of pronuclear dynamics in human zygotes. Continuous imaging identified early pronuclear appearance and fading events that are frequently missed by conventional fixed-point observations, reducing the incidence of misclassified zero-pronuclear embryos and enabling more accurate prediction of blastocyst quality and transfer outcomes.

Embryonic Development in Assisted Reproductive Technologies publication trend

The graph below shows the total number of articles in embryonic development in assisted reproductive technologies across all publications each year (not limited to Nature Index journals).

Technical terms

Zygote: A fertilised oocyte containing one or two pronuclei at the one-cell stage of development.

Pronucleus: A nucleus derived from the sperm or oocyte prior to their fusion in early embryogenesis.

Blastocyst: A later embryonic stage characterised by a fluid-filled cavity, inner cell mass and trophectoderm differentiation.

Vitrification: Ultra-rapid cryopreservation technique that prevents ice crystal formation, preserving embryo or oocyte viability.

Time-lapse monitoring: Continuous, non-invasive imaging of developing embryos to record morphokinetic events and guide selection.

References

1. Fatty acid supplementation during warming improves pregnancy outcomes after frozen blastocyst transfers: a propensity score-matched study. Scientific Reports (2024).
2. Time-lapse monitoring of fertilized human oocytes focused on the incidence of 0PN embryos in conventional in vitro fertilization cycles. Scientific Reports (2021).
3. Developmental potential of non- and mono-pronuclear zygotes and associated clinical outcomes in IVF cycles. Frontiers in Endocrinology (2024).
4. The Identification of Molecular Ploidy Status of Abnormal Pronuclear Zygotes Reveals a Significant Number of Euploid Blastocysts Available for Conception. Biomedicines (2024).